COPD Alternative Treatments
Links shared publicly online about this topic
Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available
fda.gov — “The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. Altern” View full resource at fda.gov
Most Recently Shared on April 13, 2010 at 8:40 pm By:
eyeonfda Health Lawyer and Pharma
FDA - Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out http://ow.ly/1y46M
Experimental Treatment for COPD in Development
jhsph.edu — “Researchers have developed a non-steroid based strategy for improving the lung--™s innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD).” View full resource at jhsph.edu
Most Recently Shared on April 13, 2011 at 8:12 pm By:
JHU Public Health Medical School
Experimental Treatment for #COPD in Development http://bit.ly/gA7BiQ
Experimental Treatment For COPD In Development
medicalnewstoday.com — “Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung's innate immune defense and decreasing inflammation that can b” View full resource at medicalnewstoday.com
Most Recently Shared on April 14, 2011 at 12:05 pm By:
MNT Clinical Trials Health News
Experimental Treatment For COPD In Development http://mnt.to/3TDz #clinicaltrials
Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available - Drugs.com MedNews
drugs.com — “Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out Alternative Treatments Available The U.S. Food and Drug Administration today announc” View full resource at drugs.com
Most Recently Shared on April 14, 2010 at 11:08 pm By:
Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out - http://bit.ly/cxfAoj
Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available
dld.bz — “The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. Altern” View full resource at dld.bz
Most Recently Shared on April 26, 2010 at 3:01 pm By:
Northside Allergy Doctor, Internist, Allergist, and Physician
Great tie into last week's earth day: FDA to remove asthma inhalers that deplete the Ozone layer.---> http://dld.bz/bvTh. Pls RT
COPD Condition Information, COPD Treatment Information and COPD Support Group
healthcentral.com — “Find information on COPD Treatment and COPD Management; Find support for COPD caregivers and patients” View full resource at healthcentral.com
Most Recently Shared on July 13, 2010 at 5:37 pm By:
COPD management and support groups: http://bit.ly/9AkA4S
Early Spiriva Treatment Slows COPD
webmd.com — “Spiriva, begun early in the course of COPD, slows loss of lung function, decreases disease exacerbations, and likely extends survival, a large clinical trial shows.” View full resource at webmd.com
Most Recently Shared on August 27, 2009 at 10:45 pm By:
Early COPD Treatment Slows Disease: Spiriva, begun early in the course of COPD, slows loss of lung function, dec.. http://bit.ly/S38fn
Current Treatments for COPD
suite101.com — “COPD has no cure but there are treatments for COPD that can really help. With medications and exercises a COPD patient can live fairly well.” View full resource at suite101.com
Most Recently Shared on January 26, 2011 at 8:50 pm By:
Current Treatments for COPD ---> http://dld.bz/HBbY
Treatment of COPD and asthma
nlhep.org — “Treatment of COPD and asthma” View full resource at nlhep.org
Most Recently Shared on August 25, 2009 at 2:01 am By:
Dr Richardson Doctor, Family Medicine Doctor, and Physician
#COPD treatment http://short.to/nrvq #1 - if smoking, stop! info from National Lung #Health Education Program
Arrhythmias in COPD
uptodate.com — “Supraventricular and ventricular arrhythmias are common among patients with chronic obstructive pulmonary disease (COPD). The reported incidence varies widely among studies because of variations in study populations (eg, patients with stable disease” View full resource at uptodate.com
Most Recently Shared on September 3, 2010 at 7:37 pm By:
Arrhythmias in COPD: http://bit.ly/ctCJ2a
Experimental treatment for COPD in development
physorg.com — “Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung's innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD). In a study published in the ...” View full resource at physorg.com
Most Recently Shared on April 13, 2011 at 6:03 pm By:
PhysOrg Health News Health News
Experimental treatment for COPD in development http://tw.physorg.com/221922215
Experimental Treatment for COPD in Development
newswise.com — “Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung--™s innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD). In a study, researchers targeted the Nrf2 pathway using sulforaphane, an ingredient that is present in broccoli in a precursor form, to enhance the Nrf2 pathway in the lung that mediates the uptake of bacteria.” View full resource at newswise.com
Most Recently Shared on April 13, 2011 at 6:41 pm By:
newswise Health Communicator and Health News
Experimental Treatment for COPD in Development: Researchers at the Johns Hopkins Bloomberg School of Public Heal... http://bit.ly/ecQz5m
Experimental Treatment for COPD in Development
newswise.com — “Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung--™s innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD). In a study, researchers targeted the Nrf2 pathway using sulforaphane, an ingredient that is present in broccoli in a precursor form, to enhance the Nrf2 pathway in the lung that mediates the uptake of bacteria.” View full resource at newswise.com
Most Recently Shared on April 13, 2011 at 6:02 pm By:
newswise Health Communicator and Health News
Experimental Treatment for COPD in Development: Researchers at the Johns Hopkins Bloomberg Sc... http://bit.ly/eVNJap | register to view
Experimental Treatment for COPD in Development
newswise.com — “Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a non-steroid based strategy for improving the lung--™s innate immune defense and decreasing inflammation that can be a problem for patients with chronic obstructive pulmonary disease (COPD). In a study, researchers targeted the Nrf2 pathway using sulforaphane, an ingredient that is present in broccoli in a precursor form, to enhance the Nrf2 pathway in the lung that mediates the uptake of bacteria.” View full resource at newswise.com
Most Recently Shared on April 13, 2011 at 6:49 pm By:
#health news: Experimental Treatment for COPD in Development: Researchers at the Johns Hopkins Bloomberg School ... http://bit.ly/e4kEn9
For Patients Facing Respiratory Failure Levosimendan May Offer New Treatment Alternative
medicalnewstoday.com — “Researchers in the Netherlands conducted a study, which revealed that people suffering from respiratory muscle weakness, which often accompanies chronic diseases, such as chronic obstructive pulm” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2011 at 10:05 am By:
For Patients Facing Respiratory Failure Levosimendan May Offer New Treatment Alternative http://mnt.to/3ZQy #copd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
JHU Public Health
Johns Hopkins Bloomberg School of Public Health, Protecting Health, Saving Lives Millions at a Time
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
